Stay updated on Clinical Trial: Fixed Dose Triple Therapy for Severe COPD
Sign up to get notified when there's something new on the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page.

Latest updates to the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page
- Check4 days agoChange DetectedScreenshots show only minor UI/formatting differences with no changes to core study information such as the title, purpose, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedCore content updated with a government funding notice and NIH Clinical Center operating status, plus a version bump from v3.1.0 to v3.2.0.SummaryDifference4%

- Check40 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.1%

- Check54 days agoChange Detected- The page now shows Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed as a minor navigation change with no substantive content impact.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has been updated to include new drug information and facility details, specifically adding information about Beclomethasone, Formoterol, and Glycopyrronium, as well as the locations of Brussels and Ghent in Belgium. Additionally, several drug categories and compounds have been added, while some previous entries have been removed.SummaryDifference9%

Stay in the know with updates to Clinical Trial: Fixed Dose Triple Therapy for Severe COPD
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Fixed Dose Triple Therapy for Severe COPD page.